GSK2018682
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2018682, covering 2017-07-07 to 2017-07-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. [Phase 1]